You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ranibizumab

Showing 26 - 50 of 714
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Wet Age-related Macular Degeneration Trial in Beijing, Wuhan, Shanghai (CMAB818, Lucentis®)

Recruiting
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
  • +3 more
Jun 14, 2022

Gain Clinical Insights Into Roche Ophthalmology Products

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • (no location specified)
Jul 25, 2022

Neovascular Age-related Macular Degeneration Trial in Beijing (TAB014 Monoclonal Antibody Injection, Ranibizumab Injection

Recruiting
  • Neovascular Age-related Macular Degeneration
  • TAB014 Monoclonal Antibody Injection
  • Ranibizumab Injection [Lucentis]
  • Beijing, China
    Peking Union Medical College Hospital
Jul 18, 2022

Proliferative Diabetic Retinopathy Trial in Beijing (preoperative group and intraoperative group)

Completed
  • Proliferative Diabetic Retinopathy
  • preoperative group and intraoperative group
  • Beijing, Beijing, China
    People's Hospital of Peking University
Jun 1, 2022

Age Related Macular Degeneration Trial in London (Ranibizumab, Aflibercept)

Completed
  • Age Related Macular Degeneration
  • London, UK, United Kingdom
    King's College Hospital NHS Foundation Trust
Apr 29, 2021

Reading Speed Improvements in Wet-AMD Patients After Ranibizumab

Completed
  • Ophthalmopathy
  • Wet Macular Degeneration
    • (no location specified)
    Jul 20, 2021

    Diabetic Macular Edema Trial in Worldwide (RO7200220, Ranibizumab, Sham Procedure)

    Recruiting
    • Diabetic Macular Edema
    • Arcadia, California
    • +29 more
    Aug 18, 2022

    Pathological Myopic Choroidal Neovascularization Trial in BeiJing (601, Ranibizumab)

    Recruiting
    • Pathological Myopic Choroidal Neovascularization
    • BeiJing, China
      Peking Union Medical College Hospital
    Jun 4, 2021

    Patients With Primary Nasal Pterygium Trial in Kota Bharu (intralesional ranibizumab)

    Completed
    • Patients With Primary Nasal Pterygium
    • intralesional ranibizumab
    • Kota Bharu, Kelantan, Malaysia
      Hospital Universiti Sains Malaysia
    May 6, 2021

    Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

    Not yet recruiting
    • Exudative Age Related Macular Degeneration
    • Ranibizumab
    • +3 more
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Nov 28, 2022

    Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML

    Withdrawn
    • Wet Macular Degeneration
    • Aflibercept 40 MG/ML [Eylea]
    • +2 more
    • Prague, Czechia
      Department of Ophthalmology, Faculty hospital Kralovske Vinohrad
    Aug 7, 2022

    Diabetic Macular Edema, Diabetic Retinopathy Trial in Querétaro City, Queretaro (DME lactose pill, DME levosulpiride, DR lactose

    Recruiting
    • Diabetic Macular Edema
    • Diabetic Retinopathy
    • DME lactose pill
    • +7 more
    • Querétaro City, Queretaro, Mexico
    • +1 more
    Oct 31, 2022

    Macular Degeneration Trial (Zimura, Avastin, Lucentis)

    Completed
    • Macular Degeneration
    • (no location specified)
    Oct 4, 2022

    Neovascular (Wet) Age-related Macular Degeneration Trial (BAT5906 injection, Lucentis)

    Not yet recruiting
    • Neovascular (Wet) Age-related Macular Degeneration
    • (no location specified)
    Jun 26, 2022

    Diabetic Macular Edema, Hard Lipid Exudates Trial in United States (ranibizumab 0.3mg)

    Completed
    Has Results
    • Diabetic Macular Edema
    • Hard Lipid Exudates
    • ranibizumab 0.3mg
    • Huntington Beach, California
    • +3 more
    Jul 6, 2021

    Age Related Macular Degeneration, Diabetic Macular Edema, Macular Edema Trial in Toronto (Intravitreal ranibizumab)

    Recruiting
    • Age Related Macular Degeneration
    • +3 more
    • Intravitreal ranibizumab
    • Toronto, Ontario, Canada
    • +1 more
    Apr 27, 2021

    Retinal Revascularization and Clinical Indicators of Neovascular

    Recruiting
    • Wet Macular Degeneration
    • Ophthalmic Drugs
    • Arendal, Agder, Norway
      Sorlandet Hospital HF
    Mar 3, 2022

    Radiation Retinopathy Trial in United States (0.5 mg ranibizumab, Targeted Retinal Photocoagulation (TRP))

    Completed
    Has Results
    • Radiation Retinopathy
    • 0.5 mg ranibizumab
    • Targeted Retinal Photocoagulation (TRP)
    • Dallas, Texas
    • +3 more
    Mar 24, 2021

    Anti-VEGF in Real-world

    Recruiting
    • Neovascular Age-related Macular Edema
    • +5 more
    • Ranibizumab
    • +2 more
    • Beijing, Beijing, China
      Wen-Bin Wei
    Feb 2, 2022

    Wet Age-related Macular Degeneration Trial in Boston, Worcester (Intravitreal anti-VEGF, Intravitreal AAVCAGsCD59, Oral

    Completed
    • Wet Age-related Macular Degeneration
    • Intravitreal anti-VEGF
    • +2 more
    • Boston, Massachusetts
    • +1 more
    May 24, 2022

    Macular Edema Trial in Shenyang (Ranibizumab Ophthalmic and Intravitreal Dexamethasone, Ranibizumab Ophthalmic only)

    Unknown status
    • Macular Edema
    • Ranibizumab Ophthalmic and Intravitreal Dexamethasone
    • Ranibizumab Ophthalmic only
    • Shenyang, Liaoning, China
      He Eye Specialist Hospital
    Oct 20, 2020

    Neovascular (Wet) Age-related Macular Degeneration (AMD) Trial in United Kingdom (Stereotactic radiotherapy (16 Gray or Sham),

    Active, not recruiting
    • Neovascular (Wet) Age-related Macular Degeneration (AMD)
    • Stereotactic radiotherapy (16 Gray or Sham)
    • 0.5 mg ranibizumab
    • Huntingdon, Cambridgeshire, United Kingdom
    • +29 more
    Apr 1, 2022

    Diabetic Retinopathy Trial in Nantong (Ranibizumab Injection [Lucentis], Inner limiting membrane stripping, Dexamethasone

    Recruiting
    • Diabetic Retinopathy
    • Ranibizumab Injection [Lucentis]
    • +2 more
    • Nantong, Jiangsu, China
      Affiliated Hospital of Nantong University
    Mar 7, 2022

    Uveitis, Macular Edema Trial in Worldwide (Dexamethasone intravitreal implant 0.7 mg, Intravitreal Methotrexate 400 µg,

    Completed
    • Uveitis
    • Macular Edema
    • Dexamethasone intravitreal implant 0.7 mg
    • +2 more
    • Los Angeles, California
    • +32 more
    Mar 31, 2022

    Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)

    Recruiting
    • Diabetic Macular Edema
    • Cataract
    • Walnut Creek, California
      Bay Area Retina Associates
    Mar 1, 2022